
Digital tools are increasingly being explored as a way to support patients after cancer treatment—but how do clinicians actually feel about them?
A recent study called Clinician Perspectives on the Development of a Survivorship Care Plan Smartphone Application: A Qualitative Thematic Analysis looked at clinician perceptions of a survivorship app (POSTHOC), highlighting both the potential value of these tools and the concerns that still need to be addressed. The findings are a useful lens for understanding how digital survivorship solutions can better fit into real-world care.
As someone building in this space, I found the study thoughtful—and also important to interpret in context.
One important limitation of the study is that clinicians formed their impressions based on static screenshots rather than using the app in practice. Without experiencing it within their workflows, some concerns—while valid—likely reflect limited visibility into how these tools integrate in real use.
In this article, I'm going to summarize the concerns flagged by the clinicians, the main benefits they shared. and the key takeaways that all of us need to be aware when developing and implementing a digital app for survivorship.
Clinician concerns
The study surfaced several important concerns from clinicians when evaluating digital survivorship tools:
Potential increase in workload and liability. Clinicians worried that continuous symptom tracking could generate a constant flow of data, creating expectations of real-time monitoring and raising responsibility and liability concerns.
Risk of patient overwhelm or emotional distress. There was concern that presenting too much information—or keeping cancer too present in daily life—could increase anxiety or disengagement.
Duplication with existing systems. Some clinicians noted that standalone apps could replicate work already done in electronic health records (EHRs), particularly when generating survivorship care plans.
Data privacy concerns. Collecting additional personal health data raised questions about whether patients would feel comfortable sharing sensitive information.
These concerns are valid—and highlight the importance of designing tools that integrate seamlessly into clinical workflows, respect patient preferences, and focus on delivering meaningful, actionable insights rather than more data.
Clinicians value
Despite the concerns, the study also highlights something encouraging: clinicians do see real value in these tools.
Beyond bidirectional messaging and continuous support between visits, several additional benefits stood out:
Better visibility into patient symptoms between appointments. Clinicians appreciated having access to structured patient-reported outcomes, which can help identify issues earlier rather than waiting for the next visit.
More focused and efficient consultations. By having insights ahead of time, appointments can be more targeted, allowing clinicians to spend time on what matters most.
Improved patient engagement. Tools that encourage patients to reflect on their symptoms and wellbeing can lead to more active participation in their care.
Support during the transition to survivorship. The period after treatment is often under-supported, and clinicians recognized the value of having a tool that maintains continuity during this phase.
These points reflect a broader shift in how care is delivered moving from episodic interactions to more continuous, patient-centered support.
This is where digital tools can play a meaningful role: not by replacing clinical care, but by extending it in a way that is more responsive and informed.
Key takeaways: how to successfully develop and implement a survivorship app
The study, combined with our experience building in this space, points to a few clear principles for designing and implementing digital survivorship tools effectively:
Integrate into existing workflows. Tools should complement clinical systems not compete with them. Seamless alignment with care pathways and integration with EHRs are critical to avoid duplication and clinician burden.
Prioritize signal over noise. Not all data is useful. Smart triaging, automated thresholds, and clear escalation pathways help ensure that clinicians only see what truly requires attention.
Design for patient psychology, not just functionality. Survivorship is an emotional journey. Content should be delivered gradually, with a focus on empowerment rather than overwhelm.
Make participation optional and flexible. Not every survivor wants the same level of engagement. Giving patients control over how and when they interact increases both trust and adherence.
Be transparent about data use. Patients are more willing to share data when they understand its purpose. Clear communication, strong privacy standards, and user control are essential.
Focus on extending care, not replacing it. The most effective tools support continuity between visits, helping clinicians stay informed while enabling patients to feel supported in their day-to-day lives.
Conclusion
Digital survivorship tools are not a replacement for clinical care but they can extend it. The key is thoughtful design: aligning with clinical workflows, respecting patient preferences, and focusing on meaningful outcomes rather than more data.
Studies like this are an important step forward. They highlight both the promise of digital health and the work still needed to make these tools truly useful in practice.
If we get this right, we can help close one of the biggest gaps in oncology today: what happens after treatment ends.


